
Inorganic Chemistry p. 5986 - 6000 (2002)
Update date:2022-08-05
Topics:
Evans, Daniel R.
Huang, Mingsheng
Fettinger, James C.
Williamst, Tracie L.
The ligation properties of three new upper-rim-substituted calix[4]arene ligands, 5,17-bis(hydroxymethyl)-tetra-n-butoxycalix-[4]arene ((HOCH2)2-nBu4Clx, 7), 5,17-bis((diphenylphosphinito)methoxy)-tetra-n-butoxycalix[4]arene ((PPh2OCH2)2nBu4Clx, 8), and 5,17-bis((diphenylphosphino)methyl)-tetra-n-butoxycalix[4]arene ((PPh2CH2)2-nBu4Clx, 10) are reported herein. The newly prepared compounds differ from previously reported diametrically substituted calix[4]arene derivatives in that the lower-rim substituent was n-butyl. The presence of this lower-rim substituent did not reduce the inherent crystallinity of these complexes as purification of all materials occurred via simple crystallizations. The key precursor for the syntheses of 8 and 10 was 7, acquisition of which occurred in six steps starting from tetra- tert-butylcalix[4]arene, 1. Calix[4]arene derivatives include, tetra-n-butoxycalix[4]arene (nBU4Clx, 3), 5,11,17,23-tetrabromo-tetra-n-butoxycalix[4]-arene (Br4-nBu4Clx, 4), 5,17-dibromo-tetra-n-butoxycalix[4]arene (Br2-nBu4Clx, 5), 5,17-bis(formyl)-tetra-n-butoxycalix[4]-arene ((CHO)2-nBu4Clx, 6), and 5,17-bis(chloromethyl)-tetra-n-butoxycalix[4]arene ((ClCH2)2-nBu4Clx, 9), all of which were synthesized using modifications of existing procedures. Characterization of all compounds occurred, when possible, using 1H, 13C, and 31P NMR, elemental analyses, FAB-MS, ESI-MS, FT-IR, and X-ray crystallography. The solid-state structures of all calix[4]arene intermediates and ligands showed that the annulus adopted the pinched-cone conformation in which the average C(5) ... C(17) intraannular separation was 4.5 ± 0.4 A. Reaction of 7 with CpTiMe3 yielded the cis-chelate, CpTi(Me)[(OCH2)2-nBu4Clx] (11), quantitatively. Data obtained using ESI-MS (positive-ion mode) confirmed the monomer formulation showed above, and 1H NMR spectra provided sufficient information to deduce the nature of the Ti coordination sphere. Reaction of 8 with cis-Cl2Pd(NCPh)2 in refluxing benzene afforded cis-Cl2Pd[(PPh2 OCH2)2-nBu4Clx] (12) in good yields. The monomeric identity of this compound was verified by both X-ray crystallography and positive-ion ESI-MS. The cis-bidentate calix[4]arene ligand did not undergo any noticeable contortion upon chelation of the PdCl2 fragment. Acidpromoted decomposition of 12 occurred in the presence of adventitious HCl and gaseous HCl, and the products of this decomposition were 9 and [μ2-ClPd(PPh2OH)(PPh2O)]2. In addition, chelates of 8 that contained Mo(CO)3L (L = NCMe (14a), NCEt (14b), and CO (14c)) showed that the mode of coordination was relatively insensitive to the identity of the metal. X-ray crystallography afforded views of the solid-state structures of 14b,c and, like 12, showed that the Mo(CO)3L fragment resided above the pinched-cone of the calix[4]arene. 1H NMR revealed that C-H/μ interactions existed between L (14a,b) and a phenyl ring of the coordinated phosphinite. Finally, the bis(diphenylphosphine)calix[4]arene ligand (10) readily coordinated the Mo(CO)3L species, but the reaction did not go to completion, as evidenced by 1H NMR, even after a 5 day reaction time. Data suggest that the product is similar to that observed for 12 and 14, but the incomplete reaction complicated attempts to obtain pure material and prohibited definitive assignment of the coordination array.
Nantong Auxin Electronic Technology Co., LTD
Contact:86-513-88760026
Address:NO.5-1, Aoxin Road, Haian Hi-tech Development Zone, Jiangsu Province, China
Hubei Xinghuo Chemical Co., Ltd.,
Contact:13925817279 13907299441
Address:Xinghuo Fine Chemistry Industrial Park, Xiaochang County, Hubei Province, China
Chongqing Changfeng Chemical Co., Ltd.
website:http://www.changfengchem.com
Contact:+86-23-67896333
Address:30th Floor, Longhu Ziduxingzuo Building A, 1st Branch,YuSong Rd., Yubei District, Chongqing, China
Contact:86-21-31200601
Address:Room1618,FangzhengDaSha,No.1122 Xinjinqiao Road,Pudong New District,Shanghai ,China
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Doi:10.1021/om020404v
(2002)Doi:10.1139/v65-298
(1965)Doi:10.1081/SCC-120004851
(2002)Doi:10.1021/om020622o
(2002)Doi:10.1002/hlca.201800170
(2018)Doi:10.1021/om020605z
(2002)